Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT04116164 2023-09-25

Safety and Targeting of Anti-hk2 Antibody in mCRPC

Phase EARLY_PHASE1 Terminated

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant